Medical abortion reversal: science and politics meet

被引:7
|
作者
Bhatti, Khadijah Z. [1 ]
Nguyen, Antoinette T. [1 ]
Stuart, Gretchen S. [1 ]
机构
[1] Univ N Carolina, Dept Obstet & Gynecol, Sch Med, Chapel Hill, NC USA
关键词
medical abortion; mifepristone; reversal; MIFEPRISTONE; ACCEPTABILITY; PREGNANCY; SAFETY;
D O I
10.1016/j.ajog.2017.11.555
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Medical abortion is a safe, effective, and acceptable option for patients seeking an early nonsurgical abortion. In 2014, medical abortion accounted for nearly one third (31%) of all abortions performed in the United States. State-level attempts to restrict reproductive and sexual health have recently included bills that require physicians to inform women that a medical abortion is reversible. In this commentary, we will review the history, current evidence-based regimen, and regulation of medical abortion. We will then examine current proposed and existing abortion reversal legislation. The objective of this commentary is to ensure physicians are armed with rigorous evidence to inform patients, communities, and policy makers about the safety of medical abortion. Furthermore, given the current paucity of evidence for medical abortion reversal, physicians and policy makers can dispel bad science and misinformation and advocate against medical abortion reversal legislation.
引用
收藏
页码:315 / +
页数:6
相关论文
共 50 条
  • [31] Reversal of medication abortion with progesterone: a systematic review
    Stifani, Bianca Maria
    Lavelanet, Antonella Francheska
    BMJ SEXUAL & REPRODUCTIVE HEALTH, 2024, 50 (01) : 43 - 52
  • [32] Non-physician clinicians can safely provide first trimester medical abortion
    Yarnall, Jillian
    Swica, Yael
    Winikoff, Beverly
    REPRODUCTIVE HEALTH MATTERS, 2009, 17 (33) : 61 - 69
  • [33] Latin American women's experiences with medical abortion in settings where abortion is legally restricted
    Zamberlin, Nina
    Romero, Mariana
    Ramos, Silvina
    REPRODUCTIVE HEALTH, 2012, 9
  • [34] Medical abortion: A path to safe, high-quality abortion care in Latin America and the Caribbean
    Dzuba, Ilana G.
    Winikoff, Beverly
    Pena, Melanie
    EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2013, 18 (06) : 441 - 450
  • [35] Pain management for up to 9 weeks medical abortion - An international survey among abortion providers
    Fiala, Christian
    Cameron, Sharon
    Bombas, Teresa
    Parachini, Mirella
    Agostini, Aubert
    Lertxundi, Roberto
    Gemzell-Danielsson, Kristina
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2018, 225 : 181 - 184
  • [36] Significant Adverse Events and Outcomes After Medical Abortion
    Cleland, Kelly
    Creinin, Mitchell D.
    Nucatola, Deborah
    Nshom, Montsine
    Trussell, James
    OBSTETRICS AND GYNECOLOGY, 2013, 121 (01) : 166 - 171
  • [37] Medical abortion at home and at hospital: A trial of efficacy and acceptability
    Provansal, M.
    Mimari, R.
    Gregoire, B.
    Agostini, A.
    Thirion, X.
    Gamerre, M.
    GYNECOLOGIE OBSTETRIQUE & FERTILITE, 2009, 37 (11-12): : 850 - 856
  • [38] Home use of mifepristone for medical abortion: a systematic review
    Gemzell-Danielsson, Kristina
    Lindh, Ingela
    Brynhildsen, Jan
    Christensson, Anna
    Moberg, Klas
    Wernersson, Emma
    Johansson, Susanne
    BMJ SEXUAL & REPRODUCTIVE HEALTH, 2024,
  • [39] Serum hCG threshold to assess medical abortion success
    Le Lous, Maela
    Gallinand, Anne-Claire
    Laviolle, Bruno
    Peltier, Lucas
    Timoh, Krystel Nyangoh
    Lavoue, Vincent
    EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2018, 23 (06) : 458 - 463
  • [40] Acceptability and feasibility of medical abortion with mifepristone and misoprostol in Nigeria
    Okonofua, Friday
    Shittu, Oladapo
    Shochet, Tara
    Diop, Ayisha
    Winikoff, Beverly
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2014, 125 (01) : 49 - 52